Novartis Pharmaceuticals Cataflam (diclofenac potassium) tablets, 50 mg, 100-count bottles recall — FDA D-1516-2014
Failed Tablet/Capsule Specifications: Ink identification had rubbed off tablets in transit making them illegible to pharmacists and consumers.